Journal Article
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents
L. Shrire, J. Saunders, R. Traynor and H. J. Koornhof
European Journal of Clinical Microbiology & Infectious Diseases, 1984, Volume 3, Number 4, Pages 328-332
Journal Article
Fluorinated quinolones
A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy
R. Janknegt
Pharmacy World & Science, 1986, Volume 8, Number 1, Pages 1-21
Journal Article
Untersuchungen zum Synergismus von Ciprofloxacin mit β-Laktam-Antibiotika, Gentamicin, Minozyklin und Pipemidsäure
N. Dickgießer, S. in der Stroth and W. Wundt
Infection, 1986, Volume 14, Number 2, Pages 82-85
Journal Article
Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens
M. Diez-Enciso, G. Mas-Jimenez, A. Velasco-Cerrudo and A. Gutierrez-Altes
European Journal of Clinical Microbiology & Infectious Diseases, 1984, Volume 3, Number 4, Page 367
Journal Article
Is pelvic inflammatory disease an indication for treatment with ciprofloxacin?
D. Hägele and V. Chyský
Infection, 1988, Volume 16, Supplement - 1, Pages S48-S50
Journal Article
In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin
P. Van der Auwera
Infection, 1986, Volume 14, Number 3, Pages 142-144
Journal Article
Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers
W. Wingender, K. -H. Graefe, W. Gau, D. Förster and D. Beermann, et al.
European Journal of Clinical Microbiology & Infectious Diseases, 1984, Volume 3, Number 4, Pages 355-359
Journal Article
Cefotaxime: In vitro activity against cephalothin-resistant isolates and use in the treatment of septicemia, pneumonia, urinary tract and other severe infections
W. Graninger, S. Breyer, H. Pichler, M. Böhm and K. H. Spitzy, et al.
Infection, 1981, Volume 9, Number 1, Pages 29-33
Journal Article
In vitro activity of the newer quinolones compared with the classic ones and tobramycin
E. Boquet Jiménez, F. Dalet Escribá and L. Caballé
Infection, 1985, Volume 13, Number 4, Pages 193-196
Journal Article
In vitro activity of cefpodoxime, a new oral cephalosporin, compared with that of nine other antimicrobial agents
M. Sheppard, A. King and I. Phillips
European Journal of Clinical Microbiology & Infectious Diseases, 1991, Volume 10, Number 7, Pages 573-581